Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Changes in bone microarchitecture following kidney transplantation-Beyond bone mineral density.

Sharma AK, Toussaint ND, Elder GJ, Rajapakse CS, Holt SG, Baldock P, Robertson PL, Ebeling PR, Sorci OR, Masterson R.

Clin Transplant. 2018 Sep;32(9):e13347. doi: 10.1111/ctr.13347. Epub 2018 Aug 2.

PMID:
29984421
2.

Magnetic resonance imaging based assessment of bone microstructure as a non-invasive alternative to histomorphometry in patients with chronic kidney disease.

Sharma AK, Toussaint ND, Elder GJ, Masterson R, Holt SG, Robertson PL, Ebeling PR, Baldock P, Miller RC, Rajapakse CS.

Bone. 2018 Sep;114:14-21. doi: 10.1016/j.bone.2018.05.029. Epub 2018 May 31.

PMID:
29860153
3.

De novo or early conversion to everolimus and long-term cancer outcomes in kidney transplant recipients: A trial-based linkage study.

Ying T, Wong G, Lim W, Kanellis J, Pilmore H, Campbell S, Masterson R, Walker R, O'Connell P, Russ G, Chadban S.

Am J Transplant. 2018 Dec;18(12):2977-2986. doi: 10.1111/ajt.14948. Epub 2018 Jun 27.

PMID:
29802791
4.

Deterioration of Cortical Bone Microarchitecture: Critical Component of Renal Osteodystrophy Evaluation.

Sharma AK, Toussaint ND, Masterson R, Holt SG, Rajapakse CS, Ebeling PR, Mohanty ST, Baldock P, Elder GJ.

Am J Nephrol. 2018;47(6):376-384. doi: 10.1159/000489671. Epub 2018 May 23.

PMID:
29791896
5.

Histological and Extended Clinical Outcomes After ABO-Incompatible Renal Transplantation Without Splenectomy or Rituximab.

Chow KV, Flint SM, Shen A, Landgren A, Finlay M, Murugasu A, Masterson R, Hughes P, Cohney SJ.

Transplantation. 2017 Jun;101(6):1433-1440. doi: 10.1097/TP.0000000000001415.

PMID:
27495772
6.

Low versus high dialysate calcium concentration in alternate night nocturnal hemodialysis: A randomized controlled trial.

Masterson R, Blair S, Polkinghorne KR, Lau KK, Lian M, Strauss BJ, Morgan JG, Kerr P, Toussaint ND.

Hemodial Int. 2017 Jan;21(1):19-28. doi: 10.1111/hdi.12452. Epub 2016 Jun 30.

PMID:
27364375
7.

Emerging role of high-resolution imaging in the detection of renal osteodystrophy.

Sharma AK, Masterson R, Holt SG, Toussaint ND.

Nephrology (Carlton). 2016 Oct;21(10):801-11. doi: 10.1111/nep.12790. Review.

PMID:
27042945
8.

Impact of cinacalcet pre-transplantation on mineral metabolism in renal transplant recipients.

Sharma AK, Masterson R, Holt SG, Tan SJ, Hughes PD, Chu M, Jayadeva P, Toussaint ND.

Nephrology (Carlton). 2016 Jan;21(1):46-54. doi: 10.1111/nep.12536.

PMID:
26072678
9.

ABOi with conventional immunosuppression alone-antiblood group antibody isn't the only contributor to antibody-mediated rejection and/or thrombotic microangiopathy.

Cohney S, Masterson R, Hogan C, Hughes P, Haeusler M.

Am J Transplant. 2015 Jun;15(6):1730-2. doi: 10.1111/ajt.13256. Epub 2015 Apr 24. No abstract available.

10.

ABO incompatible renal transplantation without antibody removal using conventional immunosuppression alone.

Masterson R, Hughes P, Walker RG, Hogan C, Haeusler M, Robertson AR, Millar R, Suh N, Cohney SJ.

Am J Transplant. 2014 Dec;14(12):2807-13. doi: 10.1111/ajt.12920. Epub 2014 Nov 11.

11.

Case report: thrombotic microangiopathy post-intravenous immunoglobulin in the context of BK nephropathy and renal transplantation.

Pan FF, Hidayati L, Hughes P, Murugasu A, Masterson R.

Transplant Proc. 2014 Jan-Feb;46(1):278-80. doi: 10.1016/j.transproceed.2013.10.038.

PMID:
24507067
12.

Perspective - the issues surrounding ESKD and dialysis in the elderly and those with co-morbidities.

Masterson R, Foote C.

Nephrology (Carlton). 2013 Apr 16. doi: 10.1111/nep.12070. [Epub ahead of print]

PMID:
23586734
13.

ANZSN renal supportive care 2013: opinion pieces [corrected].

Brown MA, Crail SM, Masterson R, Foote C, Robins J, Katz I, Josland E, Brennan F, Stallworthy EJ, Siva B, Miller C, Urban AK, Sajiv C, Glavish RN, May S, Langham R, Walker R, Fassett RG, Morton RL, Stewart C, Phipps L, Healy H, Berquier I.

Nephrology (Carlton). 2013 Jun;18(6):401-454. doi: 10.1111/nep.12065. Review. No abstract available. Erratum in: Nephrology (Carlton). 2014 Mar;19(3):175.

PMID:
23586687
14.

Serum protein profiles predict coronary artery disease in symptomatic patients referred for coronary angiography.

LaFramboise WA, Dhir R, Kelly LA, Petrosko P, Krill-Burger JM, Sciulli CM, Lyons-Weiler MA, Chandran UR, Lomakin A, Masterson RV, Marroquin OC, Mulukutla SR, McNamara DM.

BMC Med. 2012 Dec 5;10:157. doi: 10.1186/1741-7015-10-157.

15.

Outcomes of extended-hours hemodialysis performed predominantly at home.

Jun M, Jardine MJ, Gray N, Masterson R, Kerr PG, Agar JW, Hawley CM, van Eps C, Cass A, Gallagher M, Perkovic V.

Am J Kidney Dis. 2013 Feb;61(2):247-53. doi: 10.1053/j.ajkd.2012.08.032. Epub 2012 Oct 2.

PMID:
23036929
16.

Contributing factors for cancellations of outpatient pediatric urology procedures: single center experience.

Pohlman GD, Staulcup SJ, Masterson RM, Vemulakonda VM.

J Urol. 2012 Oct;188(4 Suppl):1634-8. doi: 10.1016/j.juro.2012.03.111. Epub 2012 Aug 19.

PMID:
22910272
17.

Dialysis modality preference of patients with CKD and family caregivers: a discrete-choice study.

Morton RL, Snelling P, Webster AC, Rose J, Masterson R, Johnson DW, Howard K.

Am J Kidney Dis. 2012 Jul;60(1):102-11. doi: 10.1053/j.ajkd.2011.12.030. Epub 2012 Mar 13.

PMID:
22417786
18.

Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease.

Morton RL, Snelling P, Webster AC, Rose J, Masterson R, Johnson DW, Howard K.

CMAJ. 2012 Mar 20;184(5):E277-83. doi: 10.1503/cmaj.111355. Epub 2012 Feb 6.

19.

KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients.

Chadban SJ, Barraclough KA, Campbell SB, Clark CJ, Coates PT, Cohney SJ, Cross NB, Eris JM, Henderson L, Howell MR, Isbel NM, Kanellis J, Kotwal SS, Manley P, Masterson R, Mulley W, Murali K, O'Connell P, Pilmore H, Rogers N, Russ GR, Walker RG, Webster AC, Wiggins KJ, Wong G, Wyburn KR; Kidney Health Australia Caring for Australians with Renal Impairment (KHA-CARI).

Nephrology (Carlton). 2012 Mar;17(3):204-14. doi: 10.1111/j.1440-1797.2011.01559.x. No abstract available.

PMID:
22212251
20.

New onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: a retrospective cohort study.

Ruderman I, Masterson R, Yates C, Gorelik A, Cohney SJ, Walker RG.

Nephrology (Carlton). 2012 Jan;17(1):89-96. doi: 10.1111/j.1440-1797.2011.01507.x.

PMID:
21854501
21.

Prediction of pre-eclampsia in early pregnancy by estimating the spot urinary albumin: creatinine ratio using high-performance liquid chromatography.

Baweja S, Kent A, Masterson R, Roberts S, McMahon LP.

BJOG. 2011 Aug;118(9):1126-32. doi: 10.1111/j.1471-0528.2011.02960.x. Epub 2011 Apr 12.

22.

Renal palliative care in Australia: time to engage.

Brown MA, Masterson R.

Nephrology (Carlton). 2011 Jan;16(1):2-3. doi: 10.1111/j.1440-1797.2010.01417.x. No abstract available.

PMID:
21175970
23.

Propagation and culture of renal fibroblasts.

Grimwood L, Masterson R.

Methods Mol Biol. 2009;466:25-37. doi: 10.1007/978-1-59745-352-3_3.

PMID:
19148603
24.

The advantages and disadvantages of home hemodialysis.

Masterson R.

Hemodial Int. 2008 Jul;12 Suppl 1:S16-20. doi: 10.1111/j.1542-4758.2008.00290.x. Review.

PMID:
18638235
25.

Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis.

Hewitson TD, Mookerjee I, Masterson R, Zhao C, Tregear GW, Becker GJ, Samuel CS.

Endocrinology. 2007 Feb;148(2):660-9. Epub 2006 Nov 9.

PMID:
17095590
26.

Effect of inhibition of farnesylation and geranylgeranylation on renal fibrogenesis in vitro.

Masterson R, Kelynack K, Hewitson T, Becker G.

Nephron Exp Nephrol. 2006;102(1):e19-29. Epub 2005 Sep 20.

PMID:
16179803
27.

Impact of statin treatment on 1-year functional and histologic renal allograft outcome.

Masterson R, Hewitson T, Leikis M, Walker R, Cohney S, Becker G.

Transplantation. 2005 Aug 15;80(3):332-8.

PMID:
16082328
28.

Relaxin regulates collagen overproduction associated with experimental progressive renal fibrosis.

Samuel CS, Mookerjee I, Masterson R, Tregear GW, Hewitson TD.

Ann N Y Acad Sci. 2005 May;1041:182-4.

PMID:
15956704
29.

Wegener's granulomatosis in pregnancy: a novel approach to management.

Masterson R, Pellicano R, Bleasel K, McMahon LP.

Am J Kidney Dis. 2004 Oct;44(4):e68-72.

PMID:
15384037
30.

Early identification of individuals with prostate cancer in negative biopsies.

Dhir R, Vietmeier B, Arlotti J, Acquafondata M, Landsittel D, Masterson R, Getzenberg RH.

J Urol. 2004 Apr;171(4):1419-23.

PMID:
15017188
31.

Relaxin down-regulates renal fibroblast function and promotes matrix remodelling in vitro.

Masterson R, Hewitson TD, Kelynack K, Martic M, Parry L, Bathgate R, Darby I, Becker G.

Nephrol Dial Transplant. 2004 Mar;19(3):544-52.

PMID:
14767007
32.

Antibiotic prescribing must improve.

Masterson R.

Hosp Med. 2003 May;64(5):312. No abstract available.

PMID:
12789747
33.

Sirolimus: a single center experience in combination with calcineurin inhibitors.

Masterson R, Leikis M, Perkovic V, Nicholls K, Walker R.

Transplant Proc. 2003 May;35(3 Suppl):99S-104S.

PMID:
12742476
34.

Late allograft loss due to recurrence of p-ANCA-associated systemic vasculitis in a patient with relapsing polychondritis.

Masterson R, Sheerin N, Abbs I, Goldsmith D.

Nephrol Dial Transplant. 2001 Aug;16(8):1705-7. No abstract available.

PMID:
11477180
35.

Clinical governance and infection control in the United Kingdom.

Masterson RG, Teare EL.

J Hosp Infect. 2001 Jan;47(1):25-31. Review.

PMID:
11281117
36.

Recovery of renal function following prolonged ischaemia in a patient with Mid-Aortic Syndrome.

Masterson R, Scoble J, Taylor P, Cook G.

Nephrol Dial Transplant. 2000 Sep;15(9):1461-3. No abstract available.

PMID:
10978411
37.

Antibiotic policies and the role of strategic hospital leadership.

Masterson RG.

J Hosp Infect. 1999 Dec;43 Suppl:S261-4.

PMID:
10658789
39.

Characterisation of a new allele of pale cress and its role in greening in Arabidopsis thaliana.

Grevelding C, Suter-Crazzolara C, von Menges A, Kemper E, Masterson R, Schell J, Reiss B.

Mol Gen Genet. 1996 Jul 19;251(5):532-41.

PMID:
8709959
40.
41.
42.

New plant binary vectors with selectable markers located proximal to the left T-DNA border.

Becker D, Kemper E, Schell J, Masterson R.

Plant Mol Biol. 1992 Dec;20(6):1195-7.

PMID:
1463855
43.

Expression of a calmodulin methylation mutant affects the growth and development of transgenic tobacco plants.

Roberts DM, Besl L, Oh SH, Masterson RV, Schell J, Stacey G.

Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8394-8.

44.

High rates of Ac/Ds germinal transposition in Arabidopsis suitable for gene isolation by insertional mutagenesis.

Grevelding C, Becker D, Kunze R, von Menges A, Fantes V, Schell J, Masterson R.

Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6085-9.

45.

Improved method for the transformation of Arabidopsis thaliana with chimeric dihydrofolate reductase constructs which confer methotrexate resistance.

Kemper E, Grevelding C, Schell J, Masterson R.

Plant Cell Rep. 1992 Apr;11(3):118-21. doi: 10.1007/BF00232162.

PMID:
24213542
46.

Functional analysis of cis-elements, auxin response and early developmental profiles of the mannopine synthase bidirectional promoter.

Leung J, Fukuda H, Wing D, Schell J, Masterson R.

Mol Gen Genet. 1991 Dec;230(3):463-74.

PMID:
1766442
47.
48.

An embryogenic cell line of maize from A188 (Minnesota) contains Mu1-like elements.

Masterson RV, Biagi K, Wheeler JG, Stadler J, Morris DW.

Plant Mol Biol. 1988 May;10(3):273-9. doi: 10.1007/BF00027404.

PMID:
24277521
49.

A technique for avoidance of hypothermia during prolonged mechanical circulatory support with centrifugal pumps.

Young JN, Belz R, Iverson LI, Ennix CL Jr, Ecker RR, May RD, Masterson R, May IA.

Ann Thorac Surg. 1987 Jul;44(1):90.

PMID:
3606268
50.

Supplemental Content

Loading ...
Support Center